EC Pulmonology and Respiratory Medicine

Literature Review Volume 12 Issue 6 - 2023

The Role of Conceptual Views in the Diagnostics of Systemic Vasculitis and Granulomatosis with Polyangiitis

Eduard Khodosh*

Kharkiv National Medical University, Kharkiv, Ukraine

*Corresponding Author: Eduard Khodosh, Kharkiv National Medical University, Kharkiv, Ukraine.
Received: April 06, 2023; Published:May 31, 2023

Renaming of Wegener's granulomatosis in granulomatous polyangitis (GPA) was caused by the urgent need to revise the existing classification of systemic vasculitis (SV) and to improve terminology that could most fully reflect the pathomorphological features of the disease. Diagnosis of GPA and SV, as well as of any other diseases is inherently associated with their clinical dynamics. That is, recognizing that we can change our minds, if we are obliged to do this by facts, is a feature of the diagnostic process. In turn, for the facts to make us change our minds, the facts themselves must exist. Thus, we must identify them and come to the opinion of what is the fact and what is not, in the context of this or that pathology. Checking the correctness of the established diagnosis is often a difficult process, and does not always prove that the diagnosis is accurate.

Keywords: Granuloma; Wegener; Granulomatosis with Polyangitis; Primary Systemic Vasculitis; Proteinase- 3; Giant Multinucleate Cells; ANCA-Аssociated Vasculitis

  1. Falk R., et al. “Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. A joint proposal of the American College of Rheumatology, the American Society of Nephrology, and the European League against Rheumatism”. Arthritis and Rheumatology 4 (2011): 863-864.
  2. Nasonov EL. “Clinical guidelines. Rheumatology”. Ed. E.L. Nasonov. Moscow: GEOTAR-Media (2006): 288.
  3. Yakovenko OK and Yakovenko TL. “ANCA-associated systemic vasculitis in the practice of a pulmonologist”. Clinical Immunology, Allergology, Infectology97 (2016).
  4. Yates M., et al. “EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis”. Annals of Rheumatic Diseases 9 (2016): 1583-1594.
  5. Kolesnik NA. “Kidney damage due to rheumatic diseases”. Kyiv (2004): 280.
  6. Lapin SV and Topolyan AA. “Immunological laboratory diagnosis of rheumatic diseases”. A guide for doctors. SPb.: Man (2006): 128.
  7. Nebyltsova OV., et al. “SYNEVO Laboratory Handbook”. K.: Doctor-Media (2013): 644.
  8. Ulrich Leishner. “Autoimmune liver disease and cross-syndrome”. Per. with him. A. Sheptulin. M.: Anacharsis (2005): 176.
  9. Krutko VS., et al. “Pulmonology: external symptoms”. Kharkov: NTMT (2011): 186.
  10. Krutko VS., et al. “Wegener's granulomatosis (prevalence, cause, diagnosis, own observations)”. News of Medicine and Pharmacy 530 (2015): 63-72.
  11. Gavrisyuk VK. “Essays in Clinical Pulmonology”. Kyiv (2016): 336.
  12. Francel SK and Jayne D. “Pulmonary Vasculitides”. Clinics in Chest Medicine 31 (2010): 519-536.
  13. Pyle K and Kennedy L. “Diagnosis and treatment in rheumatology. Problem approach”. Per. from English. Ed. ON THE. Shestak. Moscow: GEOTAR-Media (2011): 368.

Eduard Khodosh. "The Role of Conceptual Views in the Diagnostics of Systemic Vasculitis and Granulomatosis with Polyangiitis". EC Pulmonology and Respiratory Medicine  12.6 (2023): 51-64.